Literature DB >> 32289852

Using single-operator cholangioscopy for endoscopic evaluation of indeterminate biliary strictures: results from a large multinational registry.

Majid A Almadi1, Takao Itoi2, Jong Ho Moon3, Mahesh K Goenka4, Dong Wan Seo5, Rungsun Rerknimitr6, James Y Lau7, Amit P Maydeo8, Jong Kyun Lee9, Nam Q Nguyen10, Saad K Niaz11, Randhir Sud12, Tiing Leong Ang13, Abdulrahman Aljebreen1, Benedict M Devereaux14, Rakesh Kochhar15, Jörg Reichenberger16, Ichiro Yasuda17, Arthur J Kaffes18, Masayuki Kitano19, Joyce Peetermans20, Pooja G Goswamy20, Matthew J Rousseau20, D Nageshwar Reddy21, Sundeep Lakhtakia21, Yun Nah Lee3, Vijay Kumar Rai4, Kentaro Kamada2, Reina Tanaka2, Ryosuke Tonozuka2, Akihiko Tsuchida2, Tae Jun Song5, Mohan K Ramchandani21.   

Abstract

BACKGROUND: Peroral cholangioscopy (POCS) of indeterminate biliary strictures aims to achieve a diagnosis through visual examination and/or by obtaining targeted biopsies under direct visualization. In this large, prospective, multinational, real-life experience of POCS-guided evaluation of indeterminate biliary strictures, we evaluated the performance of POCS in this difficult-to-manage patient population.
METHODS: This prospective registry enrolled patients, with indeterminate biliary strictures across 20 centers in Asia, the Middle East, and Africa. The primary end points were the ability to visualize the lesion, obtain histological sampling when intended, and an assessment of the diagnostic accuracy of POCS for malignant strictures. Patients were followed for 6 months after POCS or until a definitive malignant diagnosis was made, whichever occurred first.
RESULTS: 289 patients underwent 290 POCS procedures with intent to biopsy in 182 cases. The stricture/filling defect was successfully visualized in 286/290 (98.6 %), providing a visual diagnostic impression in 253/290 (87.2 %) and obtaining adequate biopsies in 169/182 (92.9 %). Procedure-related adverse events occurred in 5/289 patients (1.7 %). POCS influenced patient management principally by elucidating filling defects or the causes of bile duct stricture or dilation. The visual impression of malignancy showed 86.7 % sensitivity, 71.2 % specificity, 65.8 % positive and 89.4 % negative predictive value, and 77.2 % overall accuracy compared with final diagnosis. Histological POCS-guided samples showed 75.3 % sensitivity, 100 % specificity, 100 % positive and 77.1 % negative predictive value, and 86.5 % overall accuracy.
CONCLUSION: In this large, real-life, prospective series, POCS was demonstrated to be an effective and safe intervention guiding the management of patients with indeterminate biliary strictures. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2020        PMID: 32289852     DOI: 10.1055/a-1135-8980

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  4 in total

1.  Peroral cholangioscopy-guided forceps biopsy versus fluoroscopy-guided forceps biopsy for extrahepatic biliary lesions.

Authors:  Takumi Onoyama; Wataru Hamamoto; Yuri Sakamoto; Shiho Kawahara; Taro Yamashita; Hiroki Koda; Soichiro Kawata; Yohei Takeda; Kazuya Matsumoto; Hajime Isomoto
Journal:  JGH Open       Date:  2020-08-07

2.  Peroral Cholangioscopy-Guided Forceps Mapping Biopsy for Evaluation of the Lateral Extension of Biliary Tract Cancer.

Authors:  Takumi Onoyama; Wataru Hamamoto; Yuri Sakamoto; Shiho Kawahara; Taro Yamashita; Hiroki Koda; Soichiro Kawata; Yohei Takeda; Kazuya Matsumoto; Hajime Isomoto
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

3.  Metastatic Anal Squamous Cell Carcinoma Presenting as an Indeterminate Biliary Stricture Diagnosed By Cholangioscopy.

Authors:  Ritu Nahar; Ian Holmes; Jeffrey Baliff; Austin Chiang; Thomas Kowalski
Journal:  ACG Case Rep J       Date:  2022-06-23

4.  Peroral Cholangioscopy-Guided Targeted Biopsy versus Conventional Endoscopic Transpapillary Forceps Biopsy for Biliary Stricture with Suspected Bile Duct Cancer.

Authors:  Katsunori Sekine; Ichiro Yasuda; Shinpei Doi; Noriyuki Kuniyoshi; Takayuki Tsujikawa; Yuichi Takano; Masatoshi Mabuchi; Kosuke Takahashi; Masashi Kawamoto; Mikiko Takahashi; Tatsuya Aso; Tatsuhiko Miyazaki; Takuji Iwashita
Journal:  J Clin Med       Date:  2022-01-06       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.